Results 251 to 260 of about 399,014 (392)

SAMHD1 Has Differential Impact on the Efficacies of HIV Nucleoside Reverse Transcriptase Inhibitors

Antimicrobial Agents and Chemotherapy, 2014
Andrew D. Huber, E. Michailidis, Megan L. Schultz, Y. T. Ong, Nicolin Bloch, Maritza Puray-Chavez, Maxwell D. Leslie, Juan Ji, Anthony D. Lucas, K. Kirby, N. Landau, S. Sarafianos   +11 more
semanticscholar   +1 more source

Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice. [PDF]

Int J Mol Sci
Bush K, Wairkar Y, Tang SJ.
europepmc   +1 more source

Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration. [PDF]

Signal Transduct Target Ther, 2021
Narendran S, Pereira F, Yerramothu P, Apicella I, Wang SB, Ambati K, Hirahara S, Kim Y, Ambati M, Ambati VL, Huang P, Varshney A, Nagasaka Y, Fukuda S, Baker KL, Marion KM, Deussing JM, Sadda SR, Gelfand BD, Ambati J.   +19 more
europepmc   +1 more source

Fabrication of Carbon Nanodots/Platinum Functionalized Nanocomposite Hydrogel Formulation for Near‐Infrared Responsive Delivery of Doxorubicin to Promote Necroptosis for Mitigating Lung Cancer Cells: In Vitro Photodynamic Therapy

Macromolecular Materials and Engineering, EarlyView.
Representation of fabrication of carbon nanodots/platinum functionalized nanocomposite hydrogel formulation for near‐infrared responsive delivery of doxorubicin for lung cancer treatment. Abstract Lung cancer remains one of the deadliest cancers, marked by uncontrolled cell growth in the lungs and often diagnosed at later stages.
Xiaoqin An, Junjun Bai, Yuan Li
wiley   +1 more source

Liver Damage During Treatment with Reverse-Transcriptase Inhibitors in HIV Patients. [PDF]

Curr Health Sci J
Lungu GN, Diaconescu GI, Dumitrescu F, Docea OO, Mitrut R, Giubelan L, Zlatian O, Mitrut P.   +7 more
europepmc   +1 more source

Dysregulation of Monounsaturated Fatty Acids is Related to α‐Synuclein in Multiple System Atrophy

Movement Disorders, EarlyView.
Abstract Background Multiple system atrophy (MSA) is a neurodegenerative disease pathologically characterized by the presence of glial cytoplasmic inclusions (GCI) composed of α‐synuclein aggregates. In Parkinson's disease, increases in monounsaturated fatty acids (MUFA) in phospholipid membranes promote α‐synuclein binding, aggregation, and toxicity ...
Finula I. Isik, YuHong Fu, Russell Pickford, Qi Cheng, Yue Yang, Simon J.G. Lewis, Nicolas Dzamko, Glenda M. Halliday, Woojin Scott Kim   +8 more
wiley   +1 more source

Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis

, 2000
Kees Brinkman, S.M.E. Vrouenraets, Robert H. Kauffmann, Hugo M. Weigel, Jos Frissen   +4 more
openalex   +1 more source

Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors [PDF]

, 2001
David Pao
openalex   +1 more source

Clinical benefits of novel non-nucleoside reverse transcriptase inhibitors: A prospective cohort study. [PDF]

Immun Inflamm Dis
Ma S, Xie X, Fu Y, Gan L, Yang X, Kong L, Li J, Long H.   +7 more
europepmc   +1 more source

Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study. [PDF]

BMC Infect Dis, 2021
Riou J, Dupont C, Bertagnolio S, Gupta RK, Kouyos RD, Egger M, L Althaus C.   +6 more
europepmc   +1 more source